| Dr David Joseph Miner, MD | |
|
535 Saybrook Rd Ste 5, Middletown, CT 06457-4743 | |
| (860) 344-8606 | |
| (860) 344-8963 |
| Full Name | Dr David Joseph Miner |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 44 Years |
| Location | 535 Saybrook Rd Ste 5, Middletown, Connecticut |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225125933 | NPI | - | NPPES |
| 026312 | Other | CT | STATE LICENSE |
| 4064721 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 026312 (Connecticut) | Secondary |
| 207RN0300X | Internal Medicine - Nephrology | 026312 (Connecticut) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Middlesex Dialysis Center, Llc. | Middletown, CT | Dialysis facility |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Midstate Nephrology Associates Pc | 6406955764 | 3 |
News Archive
Advanced prostate cancer can be treated successfully with intermittent chemotherapy, according to a study conducted by Oregon Health & Science University Cancer Institute scientists.
Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
A retrospective case-control study of 21,008 women in Finland has found that those with intrahepatic cholestasis of pregnancy (ICP), an itchy skin condition when bile gets backed up in the liver, are significantly more likely to suffer other liver diseases later in life.
Researchers at McMaster University who study how the brain processes sound have discovered the common practice of using artificial tones in perception experiments could mean scientists are overlooking important and interesting discoveries in the field of brain research.
Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.
› Verified 1 days ago
| Entity Name | Midstate Nephrology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1689877995 PECOS PAC ID: 6406955764 Enrollment ID: O20070627000345 |
News Archive
Advanced prostate cancer can be treated successfully with intermittent chemotherapy, according to a study conducted by Oregon Health & Science University Cancer Institute scientists.
Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
A retrospective case-control study of 21,008 women in Finland has found that those with intrahepatic cholestasis of pregnancy (ICP), an itchy skin condition when bile gets backed up in the liver, are significantly more likely to suffer other liver diseases later in life.
Researchers at McMaster University who study how the brain processes sound have discovered the common practice of using artificial tones in perception experiments could mean scientists are overlooking important and interesting discoveries in the field of brain research.
Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Joseph Miner, MD 535 Saybrook Rd Ste 5, Middletown, CT 06457-4743 Ph: (860) 344-8606 | Dr David Joseph Miner, MD 535 Saybrook Rd Ste 5, Middletown, CT 06457-4743 Ph: (860) 344-8606 |
News Archive
Advanced prostate cancer can be treated successfully with intermittent chemotherapy, according to a study conducted by Oregon Health & Science University Cancer Institute scientists.
Sosei Group Corporation confirms the information released today by Novartis that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Seebri Breezhaler (glycopyrronium/NVA237) 44 mcg delivered dose (50 mcg glycopyrronium per capsule), as a once-daily inhaled maintenance bronchodilator treatment to relieve symptoms in adult patients with chronic obstructive pulmonary disease (COPD).
A retrospective case-control study of 21,008 women in Finland has found that those with intrahepatic cholestasis of pregnancy (ICP), an itchy skin condition when bile gets backed up in the liver, are significantly more likely to suffer other liver diseases later in life.
Researchers at McMaster University who study how the brain processes sound have discovered the common practice of using artificial tones in perception experiments could mean scientists are overlooking important and interesting discoveries in the field of brain research.
Liquidia Technologies today announced the Bill & Melinda Gates Foundation has made a $10 million program-related investment in the company to support the development and commercialization of safer and more effective vaccines and therapeutics. This follows recent announcements of the first Liquidia clinical trial of its lead seasonal flu candidate (LIQ001) and a collaborative agreement with the PATH Malaria Vaccine Initiative.
› Verified 1 days ago
Dr. Miklos C. Fogarasi, M.D. Nephrology Medicare: Medicare Enrolled Practice Location: 536 Saybrook Rd, Middletown, CT 06457 Phone: 860-358-2220 Fax: 860-358-2222 | |
George Agyapong, MD Nephrology Medicare: Medicare Enrolled Practice Location: 1000 Silver Street, Middletown, CT 06457 Phone: 860-262-5128 | |
Lisa Ochola-tinker, M.D. Nephrology Medicare: Accepting Medicare Assignments Practice Location: 28 Crescent St, Middletown, CT 06457 Phone: 860-358-5322 Fax: 860-358-6298 | |
Dr. James Kar-kee Yue, MD Nephrology Medicare: Not Enrolled in Medicare Practice Location: 760 Saybrook Rd, Middletown, CT 06457 Phone: 860-347-3304 Fax: 860-346-8245 | |
Mario Q Ricci Jr., MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 410 Saybrook Rd, Suite 201, Middletown, CT 06457 Phone: 860-347-4620 Fax: 860-346-9687 | |
Dr. Crispin Reynaldo Abarientos, M.D. Nephrology Medicare: Not Enrolled in Medicare Practice Location: 80 S Main St, Middletown, CT 06457 Phone: 860-358-6878 Fax: 860-358-6870 | |
Stephen M Franklin, MD Nephrology Medicare: Accepting Medicare Assignments Practice Location: 420 Saybrook Rd, Middlesex Cardiology Associates, Middletown, CT 06457 Phone: 860-347-4258 Fax: 860-704-5924 |